Fractyl Health, Inc. Common Stock (NASDAQ:GUTS) Q4 2025 Earnings Call Transcript
Fractyl Health, Inc. Common Stock (NASDAQ:GUTS) Q4 2025 Earnings Call Transcript March 24, 2026Fractyl Health, Inc. Common Stock beats earnings expectations.
Fractyl Health Inc. (GUTS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bronte Capital John Hempton | 16,905 | $7,739 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.92 | 10,416 | $19,998.72 | 501,745 | 2025-12-04 | Filing | |
| $1.28 | 17,901 | $22,979.51 | 17,901 | 2025-03-14 | Filing | |
| $1.30 | 31,000 | $40,210.10 | 31,000 | 2025-03-14 | Filing | |
| $1.17 | 8,550 | $9,964.17 | 8,550 | 2025-03-13 | Filing | |
| $1.26 | 16,129 | $20,358.02 | 16,129 | 2025-03-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.82 | 90,972 | $165,205.15 | 491,329 | 2025-01-31 | Filing | |
| $1.95 | 20,948 | $40,798.32 | 491,329 | 2025-01-30 | Filing | |
| $1.81 | 22,346 | $40,464.14 | 153,544 | 2025-01-31 | Filing | |
| $1.95 | 21,472 | $41,801.69 | 153,544 | 2025-01-30 | Filing | |
| $2.47 | 96,517 | $238,358.38 | 491,329 | 2024-11-11 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,533,006 | $2,534,117 | 0% | |
| 2. | 1,622,163 | $742,951 | 0% | |
| 3. | 1,400,000 | $640,920 | 0.54% | |
| 4. | 606,185 | $277,633 | 0% | |
| 5. | 100,000 | $45,780 | 0% |
News See All
11 Best High Volume Penny Stocks to Buy Now
After a prolonged period where mega-cap stocks dominated returns, smaller and more speculative names are starting to see renewed trading activity.
10 Best New Penny Stocks to Invest In
On December 30, TipRanks reported that the Goldman Sachs portfolio strategy research team is optimistic about small-cap stocks heading into early 2026.
Fractyl Health’s REVEAL-1 Study Shows Positive Six-Month Results for Revita in Maintaining Weight and Glycemic Control Post-GLP-1 Use
Fractyl Health Inc. (NASDAQ:GUTS) is one of the best biotech penny stocks to buy according to analysts.
10 Best Biotech Penny Stocks to Buy According to Analysts
On December 24, Jared Holz of Mizuho joined 'Power Lunch' on CNBC to talk about how to play biotech moving into 2026.
Fractyl Health, Inc. Common Stock (NASDAQ:GUTS) Q3 2025 Earnings Call Transcript
Fractyl Health, Inc. Common Stock (NASDAQ:GUTS) Q3 2025 Earnings Call Transcript November 12, 2025Fractyl Health, Inc. Common Stock misses on earnings expectations.
Fractyl Health Unveils Potent Preclinical Data for Dual GIP/GLP-1 Gene Therapy RJVA-002 for Obesity
Fractyl Health Inc. (NASDAQ:GUTS) is one of the best young stocks with huge upside potential.
12 Best Young Stocks with Huge Upside Potential
On September 15, Tom Sosnoff, Tastylive founder, joined 'Squawk Box' on CNBC to discuss the state of the IPO landscape and what to make of the surge of IPO offerings.
Fractyl Health, Inc. Common Stock (NASDAQ:GUTS) Q2 2025 Earnings Call Transcript
Fractyl Health, Inc. Common Stock (NASDAQ:GUTS) Q2 2025 Earnings Call Transcript August 12, 2025Fractyl Health, Inc. Common Stock misses on earnings expectations.
11 Best New Penny Stocks to Buy Right Now
On July 28, the Opening Bid team at Yahoo Finance and Victoria Fernandez, chief market strategist at Crossmark Global Investments, discussed the rise in cheap stock trading and what it can mean for the...
Hedge Fund Resource Center